Modernizing Drug Enforcement Act of 2019 (HR 2580, 116th Congress)

Policy Details

Policy Details

Originating Entity
Last Action
Referred to Subcommittee
Date of Last Action
May 31 2019
Congressional Session
116th Congress
Date Introduced
May 8 2019
Publication Date
May 16 2019

SciPol Summary

The Modernizing Drug Enforcement Act of 2019 (HR 2580, 116th Congress) would place all opioid receptor activators (i.e., opiates), except for those used in clinical or scientific research, into the Schedule I classification. This Act would re-schedule these drugs by amending the Controlled Substances Act (21 U.S.C. 811, 21 U.S.C. 802) to explicitly place mu opioid receptor agonists (activators) into the Schedule I classification. Currently, most opiates are classified as Schedule II drugs.

The ongoing opioid crisis in the US has prompted action from both the executive and legislative branches to address the estimated 130 individuals who die every day by opioid overdose. The most substantial government action to date was the passage of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (Public Law 115-271; SciPol Full Brief) in October 2018. In the 116th Congress, various legislative proposals — ranging from authorizing appropriations to limiting the ability of the Food and Drug Administration to approve new opioid drugs to expanding availability of opioid overdose medication — have been introduced.

SciPol Summary authored by